365 related articles for article (PubMed ID: 28162875)
1. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
Lang N; Yuan H; Yu HJ; Su MY
Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRI.
Lang N; Su MY; Yu HJ; Lin M; Hamamura MJ; Yuan H
Magn Reson Imaging; 2013 Oct; 31(8):1285-91. PubMed ID: 23290477
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of tuberculosis and metastatic cancer in the spine using dynamic contrast-enhanced MRI.
Lang N; Su MY; Yu HJ; Yuan H
Eur Spine J; 2015 Aug; 24(8):1729-37. PubMed ID: 25749725
[TBL] [Abstract][Full Text] [Related]
4. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
Lang N; Su MY; Xing X; Yu HJ; Yuan H
J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
[TBL] [Abstract][Full Text] [Related]
6. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of spinal metastases originated from lung and other cancers using radiomics and deep learning based on DCE-MRI.
Lang N; Zhang Y; Zhang E; Zhang J; Chow D; Chang P; Yu HJ; Yuan H; Su MY
Magn Reson Imaging; 2019 Dec; 64():4-12. PubMed ID: 30826448
[TBL] [Abstract][Full Text] [Related]
8. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
9. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
10. Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.
Wu S; Berg WA; Zuley ML; Kurland BF; Jankowitz RC; Nishikawa R; Gur D; Sumkin JH
Breast Cancer Res; 2016 Jul; 18(1):76. PubMed ID: 27449059
[TBL] [Abstract][Full Text] [Related]
11. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
[TBL] [Abstract][Full Text] [Related]
13. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
14. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
Jena A; Mehta SB; Taneja S
J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of thyroid nodules by DCE-MRI based on compressed sensing volumetric interpolated breath-hold examination: A feasibility study.
Huang J; Liu D; Chen J; Wang X; Tang L; Zhang J; Tan Y; Lan X; Yin T; Nickel D; Wu J; Zhang J
Magn Reson Imaging; 2024 Sep; 111():138-147. PubMed ID: 38729225
[TBL] [Abstract][Full Text] [Related]
16. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
Dutoit JC; Vanderkerken MA; Verstraete KL
Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
[TBL] [Abstract][Full Text] [Related]
17. Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast.
El Khouli RH; Macura KJ; Barker PB; Habba MR; Jacobs MA; Bluemke DA
J Magn Reson Imaging; 2009 Nov; 30(5):999-1004. PubMed ID: 19856413
[TBL] [Abstract][Full Text] [Related]
18. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
19. The kinetic analysis of breast cancer: An investigation of the optimal temporal resolution for dynamic contrast-enhanced MR imaging.
Matsukuma M; Furukawa M; Yamamoto S; Nakamura K; Tanabe M; Okada M; Iida E; Ito K
Clin Imaging; 2020 May; 61():4-10. PubMed ID: 31945688
[TBL] [Abstract][Full Text] [Related]
20. DCE-MR imaging of orbital lesions: diagnostic performance of the tumor flow residence time τ calculated by a multi-compartmental pharmacokinetic tumor model based on individual factors.
Erb-Eigner K; Asbach P; Ro SR; Haas M; Bertelmann E; Pietsch H; Schwenke C; Taupitz M; Denecke T; Hamm B; Lawaczeck R
Acta Radiol; 2019 May; 60(5):643-652. PubMed ID: 30114927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
